The DOI matches its Crossref record.
Heritable Human Genome Editing
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cited by
Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos
Alanis-Lobato, G., Zohren, J., McCarthy, A., Fogarty, N. M. E., Kubikova, N., Hardman, E., Greco, M., Wells, D., Turner, J. M. A., & Niakan, K. K. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004832117 · Cited by 234
Nelson, J. P., Selin, C. L., & Scott, C. T. (2021) · Journal of Responsible Innovation · doi:10.1080/23299460.2021.1957579 · Cited by 90
Mitochondrial DNA disorders: from pathogenic variants to preventing transmission
Gomes, T. M. B., Ng, Y. S., Pickett, S. J., Turnbull, D. M., & Vincent, A. E. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab156 · Cited by 45
Toward inclusive global governance of human genome editing
Yu, H., Xue, L., Barrangou, R., Chen, S. W., & Huang, Y. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118540118 · Cited by 27
Alex, K., & Winkler, E. C. (2023) · Journal of Medical Ethics · doi:10.1136/jme-2022-108888 · Cited by 22
“48 (p. 142) ‘Control PGT’ is a preimplantation genetic test prior to embryo transfer to control if germline GE was successful.”
BackgroundInitial heritable genome editing: mapping a responsible pathway from basic research to the clinic
Ranisch, R., Trettenbach, K., & Arnason, G. (2023) · Medicine, Health Care and Philosophy · doi:10.1007/s11019-022-10115-x · Cited by 19
“…recent report from the National Academy of Medicine, the National Academy of Sciences, and the Royal Society makes recommendations for such a translational pathway, focusing on the scientific aspects while the ethical aspects are explicitly bracketed off (National Academy of Medicine et al. 2020).”
BackgroundInfluentialMitochondrial Replacement Therapy: In Whose Interests?
Noohi, F., Ravitsky, V., Knoppers, B. M., & Joly, Y. (2022) · The Journal of Law Medicine & Ethics · doi:10.1017/jme.2022.98 · Cited by 21
Genetic therapies for neurological disorders
FitzPatrick, L., & Bird, A. P. (2021) · Human Genetics · doi:10.1007/s00439-021-02399-5 · Cited by 21
Ni, C., Wan, Z., Yan, C., Liu, Y., Clayton, E. W., Malin, B., & Yin, Z. (2022) · Journal of Medical Internet Research · doi:10.2196/31687 · Cited by 17
Shozi, B., & Thaldar, D. W. (2023) · The American Journal of Bioethics · doi:10.1080/15265161.2023.2207524 · Cited by 17
The Serious Factor in Expanded Prenatal Genetic Testing
Kleiderman, E., Rahimzadeh, V. N., Knoppers, B. M., Roy, M., Laberge, A., & Ravitsky, V. (2022) · The American Journal of Bioethics · doi:10.1080/15265161.2021.2013991 · Cited by 16
Hennen, L., Hahn, J., Ladikas, M., Lindner, R., Peissl, W., & van Est, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-10617-0 · Cited by 20
Germline genome editing: Moratorium, hard law, or an informed adaptive consensus?
Kaan, T. S.-H., Xafis, V., Schaefer, G. O., Zhu, Y., Labude, M. K., & CHADWICK, R. F. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009742 · Cited by 15
Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application
Kratzer, K., Getz, L. J., Peterlini, T., Masson, J., & Dellaire, G. (2021) · Human Genetics · doi:10.1007/s00439-021-02272-5 · Cited by 17
Thaldar, D. W., Townsend, B., Botes, M., Shozi, B., & Pillay, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256097 · Cited by 14
Efficient base editing and development in human embryos without chromosomal alterationsPreprint
Jerabek, S., Kim, J., Sung, J., Jung, C., Kulmann, M. I. R., Isado, M., Jang, H.-S., Li, M., Bhatele, S., Kappy, M. D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.30.728989 · Cited by 15
Serra, M.-À. (2021) · Mètode: Revista de difusió de la investigació de la Universitat de Valencia · doi:10.7203/metode.12.20676 · Cited by 13
Nelson, J. P., Tomblin, D. C., Barbera, A., & Smallwood, M. (2023) · Public Understanding of Science · doi:10.1177/09636625231189955 · Cited by 10
“Consensus reports from a variety of august bodies (German Ethics Council, 2019, National Academies of Sciences, Engineering, and Medicine, 2017, National Academy et al., 2020; Nuffield Council on Bioethics, 2016, 2018) have called for public engagement to guide HGE governance, but most have been…”
BackgroundGreenfield, A. (2021) · Reproduction · doi:10.1530/rep-20-0635 · Cited by 9
MacCord, K. (2024) · University of Chicago Press eBooks · doi:10.7208/chicago/9780226830506.001.0001 · Cited by 8
A Reset for Bioethics: A Statement from the Global Observatory for Genome Editing
Jasanoff, S., Hurlbut, J. B., Saha, K., Moses, J. D., Affsprung, D., Austin, H., Baylis, F. E., Evans, J. H., Hunt, T., Kysar, D. A., et al. (2025) · The CRISPR Journal · doi:10.1089/crispr.2025.0058 · Cited by 8
Human heritable genome editing and its governance: views of scientists and governance professionals
Cadigan, R. J., Waltz, M., Conley, J. M., Major, R., Branch, E., Juengst, E. T., & Flatt, M. A. (2024) · New Genetics and Society · doi:10.1080/14636778.2024.2404061 · Cited by 7
Considering Reprogenomics in the Ethical Future of Fetal Therapy Trials
Farrell, R. M., & Michie, M. (2022) · The American Journal of Bioethics · doi:10.1080/15265161.2022.2027558 · Cited by 7
Therapeutic genome editing: regulatory horizons
Hines, P. A., Agricola, E., Llinares, J., O’Dwyer, L., & Herold, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/d41573-021-00130-7 · Cited by 6
Chin, A. H. B., Alón, I., Weerasekera, T. A., Bosenge-Nguma, J. D., & Sun, N. (2025) · Health Care Analysis · doi:10.1007/s10728-025-00521-6 · Cited by 6
Programming Evolution: A Crack in Science
Longo, G. O. (2021) · Organisms. Journal of Biological Sciences · doi:10.13133/2532-5876/17538 · Cited by 8
The impact of the three major human genome editing reports on the governance landscape
Conley, J. M., Robinson, A., Wilson, R., Kuczynski, K. J., & Henderson, G. E. (2025) · Journal of Community Genetics · doi:10.1007/s12687-025-00809-z · Cited by 5
CRISPR‐Cas9 and beyond: identifying target genes for developing disease‐resistant plants
Park, H. J., Kim, M., Lee, D., Kim, H. J., & Jung, H. W. (2024) · Plant Biology · doi:10.1111/plb.13625 · Cited by 5
Slokenberga, S., Minssen, T., & Nordberg, A. (2023) · Brill | Nijhoff eBooks · doi:10.1163/9789004526136 · Cited by 5
Genetic Modification of Human Embryos: Limits
Savvina, O. V. (2022) · Ethical Thought · doi:10.21146/2074-4870-2022-22-1-124-134 · Cited by 4
van Baalen, S., Srinivas, K. R., & He, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-10617-0_8 · Cited by 4
Experts’ perspectives on human gene editing in Switzerland
Berlincourt, J., Gächter, S., Vayena, E., & Ormond, K. E. (2024) · Journal of Community Genetics · doi:10.1007/s12687-024-00757-0 · Cited by 3
Towards societal alignment in the governance of human germline genome editing in the Netherlands
van der Weij, F., Bührman, E. A. M., van El, C. G., Arets, D., Timmis, J. K., & van Baalen, S. (2025) · Journal of Responsible Innovation · doi:10.1080/23299460.2025.2587982 · Cited by 3
The beginning of becoming a human
Loseva, P. A., & Gladyshev, V. N. (2024) · Aging · doi:10.18632/aging.205824 · Cited by 4
Gene Editing: How Can You Ask “Whether” If You Don't Know “How”?
Cwik, B. (2021) · The Hastings Center Report · doi:10.1002/hast.1256 · Cited by 3
CRISPR-Cas9: el debate bioético más allá de la línea germinal
Infante-López, D. V., Céspedes-Galvis, M. F., & Flórez, Á. M. W. (2022) · Persona y Bioética · doi:10.5294/pebi.2021.25.2.9 · Cited by 3
Geuverink, W. P., der Wal, J. T. G.-V., Cornel, M. C., Peerbolte, L. J. L., Prinds, C., van El, C. G., & Martin, L. (2024) · Humanities and Social Sciences Communications · doi:10.1057/s41599-024-03576-3 · Cited by 2
Gene therapy and editing in the treatment of hereditary blood disorders: Medical and ethical aspects
Alburquerque, P. C., Gómez‐Tatay, L., & Aznar, J. (2021) · Clinical Ethics · doi:10.1177/14777509211057255 · Cited by 2
Social Inequality and Human Genome Editing: A Nuanced Analysis of the Ubuntuan Ethical Prism
Afolabi, M., & Sodeke, S. O. (2023) · The American Journal of Bioethics · doi:10.1080/15265161.2023.2207526 · Cited by 2
Precision medicine: Overview and challenges to clinical implementation
Haga, S. B. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00020-1 · Cited by 2
Preclinical research (on rare diseases): we need to talk about health equity
Greenfield, A. (2024) · Mammalian Genome · doi:10.1007/s00335-024-10080-1 · Cited by 2
Fehse, B., Walter, J., Jg, R., Marx-Stölting, L., Pichl, A., & Schickl, H. (2021) · Nomos Verlagsgesellschaft mbH & Co. KG eBooks · doi:10.5771/9783748927242-219 · Cited by 1
Gene thepapy of (selected) neurological diseases
Haberlová, J., Honzík, T., & Jiruška, P. (2025) · Neurologie pro praxi · doi:10.36290/neu.2025.004 · Cited by 1
CRISPR/CAS9-Mediated Gene Editing in Human Gametes: A Review
Kumari, E., Banu, N., Marbaniang, K., Momin, F. J., & Hynniewta, B. C. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3413 · Cited by 1
CRISPR-Cas Systems: The Science and Ethics of Gene Manipulation
Poje, J. E., & Grover, N. (2022) · Learning materials in biosciences · doi:10.1007/978-3-030-90214-8_9 · Cited by 1
Reflections about the Molecular Tool That Could Change the Course of Human History: Genome Editing
Velasquez-Vasconez, P. A., & Olarte, W. T. A. (2022) · Persona y Bioética · doi:10.5294/pebi.2022.26.1.3 · Cited by 1
Evert, L. S., Potupchik, T. V., Veselova, O. F., Svetlakova, I., Panchenko, B., Kudasheva, R., & Melnikova, A. (2025) · Molekulyarnaya Meditsina (Molecular medicine) · doi:10.29296/24999490-2025-02-03 · Cited by 1
Highly efficient base editing at PCSK9 and normal human embryo development
Jerabek, S., Jung, C., Kappy, M. D., Zhao, Q., Sung, J., Wang, N., Kim, E., Kim, J., Kulmann, M. I. R., King, M. B., et al. (2026) · Nature · doi:10.1038/s41586-026-11118-x · Cited by 1
Pallitto, N., Molina, I. S., & Liotta, A. (2021) · Thémata: Revista de filosofía · doi:10.12795/themata.2021.i64.06
Potential of CRISPR-Cas System Treatment to Eradicate the COVID-19 Pandemic Caused by SARS-COV-2
Ercan, İ. (2022) · International journal of high school research · doi:10.36838/v4i4.11
III. Die Generierung von künstlichen Keimzellen: Ethische Aspekte
Ranisch, R., & Rolfes, V. (2023) · Verlag Karl Alber eBooks · doi:10.5771/9783495993958-73
Commissions, Consensus, and CRISPR
Barrangou, R. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.29107.rba
Shifting Perceptions of CRISPR
Castelyn, C. (2021) · Voices in Bioethics · doi:10.52214/vib.v7i.8595
WHO: Are You Ready for Human Genome Editing?
Montoliu, L. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.29133.lmo
La técnica CRISPR-Cas9 unos años después
Gamboa-Bernal, G. A. (2022) · Persona y Bioética · doi:10.5294/pebi.2021.25.2.1
Dederer, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-93023-3_9
Regulation of Genome Editing in Human iPS Cells: Germany
Frenken, G., & Lüttge, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-93023-3_3
Dederer, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-93023-3_1
Alkuraya, F. S. (2022) · Clinical Genetics · doi:10.1111/cge.14209
Walker, R. L., Ferguson, Z., Mitchell, L., & Waltz, M. (2024) · AJOB Empirical Bioethics · doi:10.1080/23294515.2024.2441688
“Along with hopes for advancement in treating disease and disability, current methods of genome manipulation have newly raised the specter of various forms of human enhancement – physical, cognitive, charac-terological, psychological and otherwise (National Academies of Sciences, Engineering, and Medicine 2017; Nationa…”
Waltz, M., Flatt, M. A., & Cadigan, R. J. (2025) · Journal of Community Genetics · doi:10.1007/s12687-025-00808-0
Current dilemma and future directions
Friedmann, T. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197689974.003.0023
Schaefer, G. O. (2022) · The Conversation · doi:10.64628/aai.dnrrfjwsf
Nolasco, R. E. (2025) · Journal of interdisciplinary perspectives · doi:10.69569/jip.2025.638
Creating a path to meaningful public participation: the case of heritable human genome editing
Güttinger, S. (2025) · Zeitschrift für Ethik und Moralphilosophie · doi:10.1007/s42048-025-00232-6
Guirao, P. G. (2025) · UMA Editorial eBooks · doi:10.24310/mumaedmumaed.278
Mapping the Genetics of Snoring: Insights into Family Patterns
Kadiri, S. K., & Tiwari, P. K. (2026) · Current Genomics · doi:10.2174/0113892029378464260218054551
Durmuş, Z. (2026) · Euchembioj Reviews · doi:10.62063/rev-39
“…with global standards, including registry participation and cross-border reporting, further supports collaboration and reduces uncertainty for researchers and clinicians (World Health Organization, 2021; National Academy of Medicine, National Academy of Sciences, and the Royal Society, 2020).”
InfluentialLa noción de mejoramiento humano en etapa germinal como dilema bioético
Arellanes, F. J. V. (2026) · doi:10.22201/pub.bioeticaunam.2026.3.75
Toward a Shared Decision-Making Framework for Kidney Xenotransplantation
Ahuja, H. K., Mohan, S., Cooper, D. C., Elias, N., Ahuja, N., Ladin, K., & Williams, W. W. (2026) · Current Transplantation Reports · doi:10.1007/s40472-026-00526-7
“The focus of the report was minimization of risk and the panel concluded that clinical use is impermissible unless risk to third persons is zero [54].”
Thaldar, D. W., & Pillay, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15715-8.00058-3
Kleiderman, E., Laberge, A., Dive, L. L., Ravitsky, V., Knoppers, B. M., & Boardman, F. (2026) · Journal of Community Genetics · doi:10.1007/s12687-026-00944-1 · Cited by 2
“Policies that attempt to clarify seriousness related to such interventions typically employ terms such as life-threatening or life-limiting with a focus on mortality and morbidity in early childhood (Henneman et al. 2016; Heritable Human Genome Editing 2020; Molster et al. 2017 ).”
Chronic Pain Management: Biochemical Pathways, Psychological Impacts, and Nursing Care Approaches
Almutairi, F. M., Albahuth, T. B. K., Sahli, M. Y. H., Alanazi, M. M., Al-Qaisi, M. A. H., Al-Ammari, A. H. A., Jabbari, Y. M., Aljoaid, N. D., Alotaibi, F. G., Hawi, S. A. H., et al. (2024) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2024.337882.10837
Yasmin, A. (2025) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.53555/rs40b892
Debate Before Decree:Path to Overcome Japan’s Scientific Stalemate on Heritable Human Genome Editing
Croydon, S. A., & クロイドン, シ. (2024) · Institutional Repositories DataBase (IRDB) · doi:10.18910/94576
Walter Peissl, I., & Walter Peissl, I. (2023) · Oesterreichisches Musiklexikon online (Institut für kunst- und musikhistorische Forschungen der Österreichischen Akademie der Wissenschaften)
Kamwendo, T. (2022) · ResearchSpace (University of KwaZulu-Natal)
978-3-95796-059-7-Boundary-Images.pdf
Beiguelman, G., Devries, M., Soon, W., & Tyżlik-Carver, M. (2024) · OAPEN (The OAPEN Foundation)
Transhumanismo y edición del genoma
Moya, G. E. (2022) · Repositorio Institucional UCA (Pontificia Universidad Católica Argentina)
Persemes, science fiction, and the modular human: Imagining genetically modified people in bioethics
So, D. (2025) · eScholarship@McGill (McGill) · doi:10.82308/22371
BEIGUELMAN, G., Devries, M., Soon, W., & Tyżlik-Carver, M. (2023) · Directory of Open access Books (OAPEN Foundation)
Transhumanism, Technocratic Globalism, and the Counterfeit Future
Sangwa, S., & Mutabazi, P. (2026) · doi:10.65655/4ygws009
Benson, A. K., & Ganda, F. (2022) · International Journal of Economics and Finance Studies
When “Human” Stops Tracking: An Epistemology of Boundary-Eroding Biotechnology
Zhang, X., Bao, S., & Han, L. (2026) · Global Philosophy · doi:10.1007/s10516-026-09819-z
Genetic editing in human embryos - Medical Civil Liability in the context of Germline Gene Therapy
Botas, B. P. M. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Calleja-Sordo, E. (2026) · International Journal of Feminist Approaches to Bioethics · doi:10.3138/ijfab-2024-0010
Metadata
- Authors
- International Commission on the Clinical Use of Human Germline Genome Editing, National Academy of Medicine, National Academy of Sciences, & The Royal Society
- Corresponding author
- The Royal Society
- Venue
- National Academies Press eBooks
- Publisher
- National Academies Press
- Published
- 2020-12-16
- OpenAlex
- W4249569868
- Semantic Scholar
- f64637cbc0235f8c8a9da6e071d67175778ef077
- Cited by
- 69
- References
- 0
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 8 · 2023: 7 · 2022: 16 · 2021: 15 · 2020: 1
- FWCI
- 10.23
- Type
- book
- Language
- en
- Open access
- closed
- Locations
- National Academies Press eBooks (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
- Keywords
- germline editing, human genome editing, CRISPR/Cas9, genome editing safety, germline transmission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.